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thanized by returning more of these dogs 
to their owners. 
• It holds irresponsible pet owners 
proportionately accountable for the added 
financial burden placed on the com-
munity. 
4. Ratio of Animals Altered to 
Population 
One major factor affecting the suc-
cess of a spay/neuter clinic or program is 
the number of animals altered per year 
in proportion to the population. Table 3 
contains information on programs or clin-
ics that reported a positive impact or re-
duction in the animal population. Al-
though the ratio refers to the human 
population and the number of animal 
surgeries, this formula was used as a 
basis for comparison purposes only. There 
is approximately one dog for every six 
persons. This is, therefore, a fairly con-
stant factor that can be used for deter-
mining the number of spay/neuter surge-
ries that need to be performed to reduce 
the animal population growth rate. 
Since no program or clinic has been 
in operation long enough or performed 
enough surgeries per year to report zero 
growth in the animal population, it is dif-
ficult to identify the minimum number 
of surgeries that should be performed 
per year to make a program maximally 
cost-effective and manageable. 
5. Restrictions on Income and 
Financial Need 
Six survey respondents reported that 
their program included low-income or 
financial need qualifications. Only one 
program, in Annapolis, Maryland, per-
formed enough surgeries to be an effec-
tive program. The program in Annapolis 
also included mandatory spay/neuter of 
all animals adopted from the shelter. 
Based on the survey responses concern-
ing the problem and lack of success with 
low-income restrictions, the program in 
Annapolis, Maryland, appears to be suc-
cessful in spite of the restriction on in-
come, rather than because of it. In gene-
224 
ral, limiting clients based on income crit-
eria is a factor that would handicap a 
program or clinic. 
Conclusion 
Stray and unwanted animals create 
a costly control problem that continues 
to escalate at an enormous rate. Yet, of 
all the elements that contribute to the 
cost of animal control activities, the 
stray and unwanted animals problem is 
the one that can be most effectively re-
duced. The answer is the increased ster-
ilization of the animals that are capable 
of breeding and creating the overpopu-
lation, resulting in stray and unwanted 
animals. Although sterilization is availa-
ble today, not enough pet owners choose 
to have their animals spayed or neutered 
because of the cost of the surgery and 
the lack of education regarding the 
results of animal overpopulation. Infor-
mation obtained from a survey of cities 
that have spay/neuter clinics or pro-
grams indicates that a municipally run 
spay/neuter clinic is an effective means 
of reducing the growth of the animal popu-
lation, because it provides low-cost sur-
gery, combined with education programs 
and legislation, that encourages pet owners 
to have their animals sterilized. 
A municipally run clinic would re-
duce future operating costs, based on its 
reduction in the growth of the animal 
population, and would also provide other 
indirect benefits. Animal Control per-
sonnel would have more time to enforce 
the Animal Ordinance, which would re-
sult in an increase in the percentage of 
the animal population being licensed. 
This would also produce additional reve-
nue and reduce the number of violations 
of lease and licensing ordinances. Such 
a clinic must provide low-cost spay/neu-
ter surgery to all residents and must also 
support the veterinary needs of the City 
Animal Shelter. 
In some cities, development of a 
municipally run spay/neuter clinic has 
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been opposed by local veterinarians, 
who consider it to be an infringement on 
the rights of the public sector of their 
profession. Although education programs 
sponsored by the Animal Control Divi-
sion to promote responsible pet owner-
ship would indirectly increase the de-
mand for veterinary services, it is not 
known to what extent this would offset 
income lost from those pet owners who 
would choose to obtain low-cost spay/ 
neuter surgery from a veterinary clinic. 
None of the surveyed cities that have suc-
cessfully developed their own clinic re-
ported any adverse impact on local vet-
erinarians attributable to the clinic. 
Even if a municipal clinic were to 
adversely effect income for local veteri-
narians, the need for reduction in growth 
of the animal population and the escalat-
ing costs of animal control activities 
warrant the involvement of local gov-
ernment. 
Protection of Animals 
and Animal Experimentation: 
A Survey of. Scientific Experts 
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Norbert Lagoni and Hans-joachim Wormuth are with the Institute for Veterinary Medicine [Robert von Ostertag 
Institute] and the Federal Health Office, 100 Berlin 33, Thielal/ee 88-92. Joachim Fiebelkorn is a graduate in 
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Health Office in 1982, entitled Tierschutz und Tierexperiment- Durchfuhrung, Bewertung und Aussage 
von Tierversuchen und alternativen Verfahren, bga-Bericht/81, Dietrich Reimer Verlag, Berlin, 1981. 
This artiCle summarizes information from a survey of biomedical scientists, spe;-
cifically pharmacologists and toxicologists, on the use of laboratory animals and the 
potential for replacing their use with alternative methods for the development and 
evaluation of pharmaceutical substances. The majority of those surveyed felt that the 
alternatives could supplement or complement animal tests, but not replace the tests 
altogether. However, most favored the use of nonsentient material in safety tests. 
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Zusammenfassung 
Dieser Artikel ist eine Zusammenfassung von Resultaten einer Untersuchung 
untel biomedizinischen Wissenschaftlern, insbesonders von Pharmakologen und 
Toxikologen, uber die Verwendung von Versuchstieren und ihres moglichen Ersatzes 
durch alternative Methoden in der Entwicklung und Auswertung pharmazeutischer 
Substanzen. Die Mehrzahl der befragten Wissenschaftler ausserten die Meinung, 
dass Alternativen wahl Tierversuche unterstlitzen oder vervollstandigen, jedoch 
nicht ganzlich ersetzen konnten. Die meisten von ihnen sprachen sich jedoch 
zugunsten der Verwendung von nicht-empfindsamer Materie in Sicherheitstesten aus. 
Introduction 
To an increasing extent, animal ex-
periments have become a subject of 
public discussion. There are some social 
groups who assert again and again that 
animal experiments are dispensable in 
many biomedical fields because they 
can now be replaced by alternative 
methods. We report how, for the first 
time in the German-speaking area, scien-
tists of various disciplines, who hold dif-
ferent attitudes toward the problems in-
volved, were surveyed by questionnaire 
on the subject of toxicological evalua-
tion of pharmaceutical substances using 
animal tests. Information was sought on 
the value of animal experiments for safety 
evaluation in acute, subacute, chronic, 
mutagenicity, carcinogenicity, and em-
bryotoxicity studies. The questionnaire 
also asked for the scientists' assessment 
of alternative methods and their reliabil-
ity. 
Method 
Information was collected by 
means of a written questionnaire be-
tween the end of June to mid-August of 
1980. The addresses of the persons to be. 
interviewed had been taken from lists of 
university lecturers, participants at 
various conferences, and the membership 
I ist of the German Pharmacological So-
ciety. Additionally, the questionnaire 
was sent to all medical societies and 
associations. Questionnaires were sent 
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to a total of 1 ,526 scientists from the 
fields of pharmacology and toxicology, 
veterinary medicine, pharmaceutics, bio-
logy, genetics, biochemistry, and physi-
ology. These scientists were affiliated 
with universities, industry, and govern-
mental and private research institutions. 
There was a 60 percent (916 question-
naires) response, but only 682 question-
naires were evaluated; the rest arrived 
too late for analysis or were incomplete. 
Disciplines, Experience in Animal 
Experimentation, and Fields of 
Activity 
The majority of responses came 
from pharmacologists and toxicologists 
(53.6 percent), while scientists in phar-
maceutics and biochemistry accounted 
for approximately 10 percent each. Veter-
inarians accounted for a further 3 per-
cent, with the remainder (about 24 per-
cent) coming from biology or other dis-
ciplines. Two-thirds of those responding 
used animals in experiments. The "typi-
cal" period of experience in animal re-
search was found to be between 15 and 
20 years, and the majority of these inves-
tigators came from the disciplines of 
pharmacology, toxicology, and veterinary 
medicine. Of the pharmacologists and 
toxicologists interviewed, approximate-
ly 48 percent of the respondents were af-
filiated with universities, and only 37 
percent were affiliated with industrial 
establishments. 
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An analysis of the disciplines and 
place of employment of the 682 re-
spondents showed that approximately 
40 percent were employed by industry 
and 40 percent by universities. Approx-
imately 9 percent were employed by 
other research institutions (e.g., Max 
Planck Institutes), 6 percent in hospitals, 
and some 2 percent in governmental reg-
ulatory bodies. Of the pharmacologists 
and toxicologists surveyed, approximately 
48 percent were employed by industrial 
establishments and approximately 40 per-
cent by universities, whereas approx-
imately 61 percent of the pharmacists 
worked in industry, while only .26 per-
cent were affiliated with university in-
stitutions. In contrast, most of the bio-
chemists, veterinarians, and biologists 
surveyed were affiliated with universities 
and research institutions. 
Results and Conclusions 
It is important to note that those 
whose answers indicated insufficient knowl-
edge were not included in the final cal-
culations of percentages. Of those that re-
mained, it was found that these re-
spondents did not consider that animal 
experiments could be replaced by alter--
natives in testing for toxicity at present. 
They felt that alternative methods, if ap-
plicable, could be used as supplements 
or complements, but not replacements. 
Also, the majority of those who were 
surveyed predicted that only small gains 
could be made in reducing the number of 
animal experiments. In fact, they argued 
for a need for more animal experiments 
and for longer periods of testing, which 
would result in the use of more experi-
mental animals and an extension of pain 
and suffering. However, the majority of 
the respondents were in favor of using 
material incapable of feeling pain in 
special (short-term) toxicological studies. 
There were some noteworthy differ-
ences of opinion on a number of issues. 
Scientists from industry and from univer-
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sities differed, in some cases, over the 
length of time necessary for chronic stud-
ies: University scientists advocated more 
extended periods of animal testing. The 
LD50 statistic was considered to be of 
great importance by 48 percent of the re-
spondents and of I ittle or no importance 
by 35 percent of the respondents. A mere 
34 percent of the respondents proposed 
that medical and scientific reasons be 
considered as the most important criteria 
in choosing appropriate animal models. 
Another 34 percent identified economic 
and regulatory requirements as being 
more important. Concerning the issue of 
the number of species required for testing, 
"two mammal species" was chosen as 
preferable by 67 percent of those who 
indicated some knowledge of the issues. 
However, 21 percent felt that three or 
more mammals should be used in testing. 
For acute toxicity testing, 42 percent felt 
that the follow-up period should be 2 
weeks, while 31 percent felt it should be 
1 week (or less), and 27 percent chose 
more than 2 weeks. 
On the question of alternatives, the 
respondents were asked to comment on 
the application of clinical data and the 
utility of mutagenicity tests. A small pro-
portion (7.7 percent) felt that data from 
chronic animal toxicity studies could be 
completely substituted by clinical data 
from human studies. Partial substitution 
was considered possible by 41.4 percent, 
and 25 percent cons ide red that su bstitu-
tion of animal data was impossible. Con-
cerning the issue of short-term tests for 
mutagenicity evaluation, 13.1 percent of 
the respondents expressed their opposi-
tion to these tests. Those who accepted 
short-term mutagenicity tests disagreed 
over when such tests should be con-
ducted. Some (20.1 percent) felt that 
short-term tests should always be done, 
while others favored them only in cases 
of suspected mutagenic effects (24.0 
percent) or in cases when it was an-
ticipated that there would be long-term 
administration of a drug (17.5 percent). 
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Discussion 
These examples indicate that there 
is considerable divergence of opinion 
among experts about the use of laborato-
ry animals. This may be due to the lack 
of any real scientific basis for the design 
and selection of animal tests for tox-
icology testing. For various reasons, in-
cluding concern about the ethical issues 
regarding use of experimental animals 
and the performance of animal experi-
ments, there seems to be an urgent need 
to create a rational bas is for animal ex-
perimentation in the field of drug safety. 
Therefore, it is recommended that ap-
propriate committees to address this is-
sue be formed within scientific societies. 
The present inquiry might provide a 
basis for such action. 
These panels should explore the 
various kinds of approaches that might 
be taken to limit or partially omit animal 
experiments in toxicology in the future. 
It is important that the inquiry be con-
ducted under carefully defined condi-
tions for each individual field of applica-
tion (e.g., acute toxicity or mutagenicity). 
The LDSO test can serve as an example. 
Experimental animals are undoubtedly 
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needed to determine an LDSO. Never-
theless, the general importance of this 
parameter for risk evaluation is a matter 
of great controversy, especially in rela-
tion to drug testing. 
Industrial drug research is already 
extensively using short-term tests, in-
volving material incapable of experienc-
ing pain, in the screening process of new 
drugs. Such tests contribute to a reduc-
tion in the consumption of experimental 
animals and to a limitation in the total 
number of animal experiments. Short-
term tests may also be used to study the 
actions or toxicological profile of an ac-
tive substance, and they are generally 
cheaper and quicker. 
It is recommended that the impor-
tance of, and the conditions for, a more 
extensive use of alternatives be studied 
more extensively. This would include co-
ordination of research activities and dis-
semination of experimental data, as well 
as the provision of funds to finance specific 
research projects. At the same time, ef-
forts should be initiated to have the con-
cept of alternative methods included in 
any new national and supranational leg-
islation that deals with toxicology test-
ing and research. 
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Does Wildlife Have 
Legal Standingl-
The Penguin Case in Patagonia 
Pedro Tarak 
Pedro Tarak is a Professor of Environmental Policy and Law at The University of Buenos Aires, Buenos Aires, 
Argentina. 
The Magellan penguin populations in the Patagonian province of Argentina were 
recently threatened by a proposed joint japanese-Argentine venture to exploit them 
on a massive scale. The firm, H in ode Penguin Argentina, wished to begin slaughtering 
what it termed "excess" penguins, and to process the dead birds into skins for the 
world market; the carcasses were to be converted to a protein extract for local con-
sumption. 
Upon learning about this venture, Argentine conservation groups mobilized their 
forces quickly- formulating and implementing media campaigns, soliciting scien-
tific opinions from local and worldwide experts, and concocting legal strategies. The 
legal tactics alone, although initially successful, eventually floundered because of a 
weakness in Argentine law: citizens cannot bring "class action" suits to court- only 
the government has jurisdiction over any area considered to be in the general domain, 
like wildlife protection. So it was the judge's eventual decision to consult with the 
Argentine president that turned the tide for the penguins. Since the president needed 
popular support, he dared not contradict the massive body of public opinion that had 
been marshaled in favor of the penguins. 
While the outcome in this case was favorable, because a whole spectrum of strate-
gies, including economic arguments, was used to exert pressure on the court and Ex-
ecutive branch to halt the Hinode scheme, similar threats could be averted more easi-
ly and quickly if Argentines could gain the basic right to bring to court "popular" or 
"citizen" suits on behalf of wildlife. 
Zusammenfassung 
Die Magalhaes Pinguin Populationen in der Patagonischen Provinz von Argenti-
nien wurden vor kurzer Zeit bedroht, und zwar durch ein gemeinsames Japanisch-
Argentinisches Unternehmen, das auf eine Ausbeutung der Pinguine in grandiosem 
Ausmass hinzielte. Die Firma "Hinode Pinguin Argentina" hatte die Absicht, mit 
dem Schlachten von dem, was sie als "Exzess"-Pinguine bezeichnete, zu beginnen 
und die Haute der getoteten Vogel zu bearbeiten, um sie auf den Weltmarkt zu 
bringen. Die Tierleichen sollten zu einem Protein Extrakt fUr den lokalen Konsum 
verarbeitet werden. 
Sowie diese Absicht bekannt wurde, mobilisierten argentinische Naturschutz-
gruppen schnell ihre Streitkrafte, planten Media-Kampagnen und flihrten sie auch 
durch, holten wissenschaftliche Meinungen von lokalen und internationalen Ex-
perten ein und entwickelten eine Strategie fUr legale Aktionen. Die legalen Taktiken, 
obwohl zu Beginn erfolgreich, scheiterten schliesslich an einer Schwache in der 
argentinischen Justiz: argentinische Staatsbl.irger konnen nicht Klagen aus "Klassen 
Aktionen" vor Gericht bringen. Nur die Regierung hat J urisdiktion Uber Sachgebiete, 
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